리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 08월
페이지 정보:영문 472 Pages
라이선스 & 가격 (부가세 별도)
한글목차
ADME-독성 시험 세계 시장은 2030년까지 188억 달러에 이를 전망
2023년에 91억 달러로 추정되는 ADME-독성 시험 세계 시장은 2023-2030년간 CAGR 10.9%로 성장하여 2030년에는 188억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 세포배양 기술은 CAGR 12.9%를 나타내고, 분석 기간 종료까지 96억 달러에 이를 것으로 예측됩니다. High Throughput Screening 기술 분야의 성장률은 분석 기간중 CAGR 7.8%로 추정됩니다.
미국 시장은 42억 달러로 추정, 중국은 CAGR 14.0%로 성장할 것으로 예측
미국의 ADME-독성 시험 시장은 2023년에 42억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 15억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2023-2030년간 CAGR은 14.0%입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 7.7%와 11.7%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 10.2%를 나타낼 전망입니다.
세계 ADME-독성 시험 시장 동향 및 촉진요인 요약
ADME-독성 시험은 약리학에서 중요한 과정으로, 독성학적 프로파일과 함께 잠재적인 약제 화합물의 흡수, 분포, 대사 및 배설(ADME) 특성을 평가하는 것을 말합니다. 이러한 유형의 시험은 의약품 개발의 기본이며, 물질이 체내에서 어떻게 작용할지를 예측하는 중요한 데이터를 제공하여 의약품의 안전성과 효능에 영향을 미칠 수 있습니다. 독성시험은 의약품 후보물질이 유발할 수 있는 잠재적 부작용을 평가하고 약물 섭취와 관련된 부작용 위험을 파악하는 데 도움이 되며, ADME-독성 시험은 규제 요건일 뿐만 아니라 안전하고 효과적인 의약품만 임상시험을 거쳐 최종적으로 시장에 출시되어 공중보건을 보호하기 위한 중요한 단계입니다. 중요한 단계이기도 합니다.
ADME-독성 시험에 대한 수요는 제약 산업의 확대와 복잡한 안전성 평가가 필요한 더 복잡한 생물학적 제제의 도입과 함께 급증하고 있습니다. 최신 시험법에서는 ADME-Tox 프로파일을 효율적이고 정확하게 예측하기 위해 하이스루풋 스크리닝 및 분자 모델링과 같은 첨단 기술을 사용하는 경우가 많아지고 있습니다. 또한 in vitro 및 in silico 모델의 통합은 이러한 시험의 예측 능력을 향상시키고 동물 실험에 대한 의존도를 낮추며, 보다 윤리적인 연구 수행을 위한 전 세계적인 움직임과 일치합니다. 이러한 발전은 의약품 개발 프로세스를 가속화할 뿐만 아니라 비용 효율성을 개선하고 연구자들이 개발 주기 초기에 잠재적 실패를 선별할 수 있게 해줍니다. 표적치료제, 맞춤의료 등 새로운 치료제의 복잡성이 증가함에 따라 첨단 ADME-독성 시험을 통한 상세하고 정밀한 분석이 더욱 요구되고 있습니다.
ADME-독성 테스트 시장의 성장은 여러 가지 요인에 의해 주도되고 있습니다. 보다 빠르고 정확하며 비용 효율적인 검사 방법을 제공하는 기술 발전이 주요 촉진요인입니다. 제약회사들이 의약품 개발과 관련된 시간과 비용을 절감할 수 있는 방법을 지속적으로 모색하고 있기 때문에 이러한 첨단 기술은 점점 더 매력적으로 다가오고 있습니다. 또한, 전 세계적으로 규제 요건이 점점 더 엄격해지고 있으며, 의약품이 승인되기 전에 보다 종합적인 독성 및 유효성 데이터를 요구하고 있습니다. 이러한 규제 환경은 ADME-Tox 테스트 서비스에 대한 지속적인 수요를 보장합니다. 또한, 개인 맞춤형 의료에 대한 관심이 높아지고 치료 지수가 더 좁은 의약품의 개발로 인해 보다 상세하고 맞춤화된 독성 테스트가 요구되고 있으며, 이는 시장을 더욱 촉진하고 있습니다. 마지막으로, 의약품 개발에서 동물실험을 줄이려는 윤리적 움직임은 대체 시험관 및 체외 및 실리코 방법의 채택을 촉진하여 시장 확장을 보다 광범위한 윤리적 기준에 부합하도록 하고 있습니다. 이러한 요인들은 ADME-독성 시험 시장의 지속적인 성장을 보장하고 안전하고 효과적인 의약품 개발에서 ADME-독성 시험의 중요한 역할을 강조하고 있습니다.
조사 대상 기업 예(총 79건)
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Corning, Inc.
BD Biosciences
Charles River Laboratories International, Inc.
AB Sciex LLC
Dassault Systemes SE(3D S)
Cyprotex Limited
BioReliance Corporation
Crown Bioscience, Inc.
Envigo, Inc.
ADMEcell, Inc.
Endonovo Therapeutics, Inc.
CN Bio Innovations Ltd.
Emulate, Inc.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
라틴아메리카
중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global ADME-Toxicology Testing Market to Reach US$18.8 Billion by 2030
The global market for ADME-Toxicology Testing estimated at US$9.1 Billion in the year 2023, is expected to reach US$18.8 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$9.6 Billion by the end of the analysis period. Growth in the High Throughput Screening Technology segment is estimated at 7.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 14.0% CAGR
The ADME-Toxicology Testing market in the U.S. is estimated at US$4.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 11.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.
Global ADME-Toxicology Testing Market - Key Trends and Drivers Summarized
ADME-Toxicology Testing is a critical process in pharmacology, referring to the assessment of Absorption, Distribution, Metabolism, and Excretion (ADME) properties of potential pharmaceutical compounds alongside their toxicological profiles. This type of testing is fundamental in drug development, providing essential data that predicts how substances behave in the body, which can impact drug safety and efficacy. The toxicological tests evaluate potential adverse effects caused by drug candidates, helping to identify any toxic risk associated with drug intake. ADME-Toxicology testing is not only a regulatory requirement but also a crucial step to ensure that only safe and efficacious drugs reach clinical trials and eventually the market, thereby safeguarding public health.
The demand for ADME-Toxicology testing has surged with the expansion of the pharmaceutical industry and the introduction of more complex biologic drugs which require intricate safety assessments. Modern testing methods now often employ sophisticated technologies such as high-throughput screening and molecular modeling to predict ADME-Tox profiles efficiently and accurately. Additionally, the integration of in vitro and in silico models has enhanced the predictive capabilities of these tests, reducing the reliance on animal testing and aligning with the global push towards more ethical research practices. These advancements not only expedite the drug development process but also improve its cost-effectiveness, enabling researchers to screen out potential failures earlier in the development cycle. The increasing complexity of new therapeutic agents, including targeted therapies and personalized medicine, further necessitates the detailed and precise analysis provided by advanced ADME-Tox studies.
The growth in the ADME-Toxicology testing market is driven by several factors. Technological advancements that offer more rapid, accurate, and cost-effective testing methods are a primary driver. As pharmaceutical companies continue to seek ways to reduce the time and cost associated with drug development, these advanced technologies become increasingly attractive. Additionally, regulatory requirements have become more stringent worldwide, demanding more comprehensive toxicity and efficacy data before a drug can be approved. This regulatory landscape ensures continual demand for ADME-Tox testing services. Moreover, the growing focus on personalized medicine and the development of drugs with narrower therapeutic indices call for more detailed and customized toxicity testing, further propelling the market. Finally, the ethical push towards reducing animal testing in drug development encourages the adoption of alternative in vitro and in silico methods, aligning market expansion with broader ethical standards. These factors collectively ensure sustained growth in the ADME-Toxicology testing market, highlighting its critical role in advancing safe and effective pharmaceuticals.
Select Competitors (Total 79 Featured) -
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Corning, Inc.
BD Biosciences
Charles River Laboratories International, Inc.
AB Sciex LLC
Dassault Systemes SE (3DS)
Cyprotex Limited
BioReliance Corporation
Crown Bioscience, Inc.
Envigo, Inc.
ADMEcell, Inc.
Endonovo Therapeutics, Inc.
CN Bio Innovations Ltd.
Emulate, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
ADME-Toxicology Testing - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
ADME-Tox : An Introduction
A Prelude to ADME Toxicology Testing
Global Market Prospects and Growth Drivers
Drug Makers Bet on ADME & Toxicology Testing to Improve Success Rate for Potential Drug Candidates
Cell Culture Holds a Major Share of the Market
North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increased Need to Check Late-Stage Drug Failures Drive Market Growth
Steady Increase in Average Drug Development Cost and Efforts to Mitigate Late-Stage Drug Failure Rates Highlights the Role of ADME-Toxicology Testing: Average Cost of Drug Development (in US$ Billion) in the US since 1980s
Impact of ADME-Tox Screening on New Drug Discovery
TABLE 1: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics
actors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others
Drug Withdrawals Due to Toxicity Issues (1990-early 2010s): Percentage Share Breakdown of Number of Drugs Withdrawn Due to Cardiotoxicity, Hepatotoxicity and Others
Pharma Industry Renews Focus on Cost Optimization
China and India: Hot Spots for R&D Investment
Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge
Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis
Major Types of Cell-Based HTS Assays for Drug Screening
Cell-based Assays in HTS and UHTS
Innovation in Screening Guarantees Success for Drug Discovery Programs
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
High Content Screening - Key Application Areas
HCS Market Ripe with Growth Opportunity
HCS vs. HTS
Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses
CDER's DARS 2-Microphysiological 3D Cell Culture Platforms as Drug Development Tools
Rising Investment in Proteomics R&D Drive Cell-based Assays Market
In-Silico ADME Emerge as Compelling Drug Discovery & Development Tool
Advantages of Using In Silico Approaches
Personalized Treatments & Computational Tools: Intriguing Facets of ADME R&D ADME Pharmacogenomics to Power Personalized Treatments
ADME Research & Emerging Computational Tools
Omics Technology
Adoption of Omics-based Technologies
In Vitro 3D Organoid Models to Meet ADME-Toxicity Testing Needs
Limitations of Traditional in vitro Cellular Models
Organoids Technology-Advanced in vitro 3D Platforms for More Physiologically Relevant Modeling
Stem Cells Exude Great Potential in Drug Toxicity Testing
Global Market for Stem Cell-Assays
Functional Assays: An Effective Way of Predicting Specific Toxic Effects
GPCR Targets to Drive Growth in Functional Cell Assay Market
Molecular Imaging and ADME
Organ-on-a-Chip Technology Gains Momentum in ADME Toxicology Testing
Technological Advancements in ADME Toxicology Testing
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Molecular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Cellular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Biochemical Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Ex-Vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for In Silica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Systemic Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Renal Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Hepatotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 37: World Recent Past, Current & Future Analysis for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 38: World Historic Review for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 39: World 16-Year Perspective for Neurotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 42: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 43: World ADME-Toxicology Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 44: World Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 45: World Historic Review for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: World 16-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 47: USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: USA Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: USA 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: USA Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: USA 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: USA Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: USA 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 56: Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Canada Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Canada 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Canada Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Canada 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Canada Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Canada 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
JAPAN
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 65: Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Japan Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Japan 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Japan Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Japan 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Japan Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Japan 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
CHINA
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 74: China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: China Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: China 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: China Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: China 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: China Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: China 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
EUROPE
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 83: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Europe 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Europe 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 93: Europe Historic Review for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Europe 16-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 95: France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: France Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: France 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: France Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: France 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 101: France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: France Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: France 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
GERMANY
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 104: Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Germany Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Germany 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 107: Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Germany Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Germany 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 110: Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Germany Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Germany 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 113: Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Italy Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Italy 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 116: Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Italy Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Italy 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 119: Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Italy Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Italy 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 122: UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: UK Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: UK 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 125: UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: UK Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: UK 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 128: UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: UK Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: UK 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
SPAIN
TABLE 131: Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Spain Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Spain 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 134: Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Spain Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Spain 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 137: Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Spain Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Spain 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
RUSSIA
TABLE 140: Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Russia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Russia 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 143: Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Russia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Russia 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 146: Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Russia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Russia 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Rest of Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
LATIN AMERICA
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 167: Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Latin America 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 170: Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Latin America 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 173: Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Latin America 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
MIDDLE EAST
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 176: Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Middle East 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 179: Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Middle East 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 182: Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Middle East 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
AFRICA
ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 185: Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Africa Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Africa 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2024 & 2030
TABLE 188: Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Africa Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Africa 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2024 & 2030
TABLE 191: Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Africa Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Africa 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2024 & 2030
